Pilot or pivotal ? [General Sta­tis­tics]

posted by Ohlbe – France, 2018-06-27 15:43 (1084 d 18:21 ago) – Posting: # 18981
Views: 9,890

Hi ElMaestro,

» This is purely hypothetical for me. As far as I recall, I have not ever faced such a situation where two test formulations targeting the same authority were heads-on compared in a pivotal trial. I have faced it numerous times in pilot trials, but here the choice of formulation rarely is based on the CI but just on the observed GMR.

Precisely. But then, isn't this whole discussion on alpha correction purely hypothetical too ?

Sorry if I'm spoiling a nice thread...


Complete thread:

 Admin contact
21,523 posts in 4,499 threads, 1,523 registered users;
online 6 (2 registered, 4 guests [including 2 identified bots]).
Forum time: Wednesday 10:05 CEST (Europe/Vienna)

Don’t undertake a project
unless it’s manifestly important
and nearly impossible.    Edwin H. Land

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz